[MO8] JSNM Oral 8:Oncology 5: PRRT 1 | JSNM2025/JSNMT2025

Advanced Search

Session Details

[JSNM]Oral & PosterAnnual Scientific Meeting of the Japanese Society of Nuclear Medicine Program : 一般演題口演

JSNM Oral 8:Oncology 5: PRRT 1

Thu. Nov 13, 2025 3:20 PM - 4:20 PM JST
Thu. Nov 13, 2025 6:20 AM - 7:20 AM UTC

Room 6（B1F, Main Conference Room, Kyoto International Exhibition Hall 'Miyako Messe'）

座長：中島　良太（京都大学医学部附属病院放射線部）、高野　祥子（横浜市立大学）

[1-MO8-1]During administration of 177Lu-oxodotreotide, transient bradycardia often occur

Hirofumi Yamada¹、Kota Yokoyama¹、Junichi Tsuchiya¹、Miki Miura¹、Eriko Katsuta²、Keiichi Akahoshi²、Tomomi Akiyama³、Keisuke Takino⁴、Daisuke Ban²、Ukihide Tateishi¹ (1.Department of Diagnostic Radiology, Institute of Science Tokyo, Bunkyo-ku, Tokyo, Japan、2.Department of Hepato-Biliary-Pancreatic Surgery, Graduate School of Medicine, Institution of Science Tokyo, Tokyo, Japan.、3.Department of Nursing, Institute of Science Tokyo, Bunkyo-ku, Tokyo, Japan、4.Institute of SCIENCE TOKYO HOSPITAL. Radiology Center, Bunkyo-ku, Tokyo, Japan)

[1-MO8-2]Initial experience of¹⁷⁷Lu-DOTATATE treatment and examination of lesion accumulation

Akihiro Ichikawa、Sachiko Awata、Mizuho Ueda (Saku Central Hospital Advanced Care Center, Nagano, Japan)

[1-MO8-3]Clinical outcomes of 177Lu-DOTATATE and utility of post-PRRT scintigraphy in NETs patients

Nakashima Ryota^1,2、Yusuke Iizuka¹、Sho Koyasu^2,3、Katsuhiko Mitsumoto²、Takaharu Itagaki²、Satoshi Ueta¹、Rihito Aizawa¹、Kanae Miyake³、Shigemi Matsumoto⁴、Yuji Nakamoto³、Takashi Mizowaki¹ (1.Department of Radiation Oncology and Image-applied Therapy, Kyoto University Hospital, Kyoto, Japan、2.Division of Clinical Radiology Service, Kyoto University Hospital, Kyoto, Japan、3.Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Hospital, Kyoto, Japan、4.Department of Clinical Onocology, Kyoto University Hospital, Kyoto, Japan)

[1-MO8-4]Efficacy and safety of peptide receptor radionuclide therapy for neuroendocrine tumors

Rika Saito^1,2、Shozo Okamoto³、Shigeyasu Sugawara³、Tohru Shiga³、Reiko Kimura¹、Emi Tokuda¹、Noboru Oriuchi³、Shigehira Saji^1,2 (1.Fukushima Univ. Med.、2.Fukushima Med. Univ. Hosp.、3.Fukushima Med. Univ.)

[1-MO8-5]A case of hypothyroidism following¹⁷⁷Lu-DOTATATE therapy for pNET with liver metastases

Tomo Hiromasa¹、Norihito Akatani²、Hiroshi Wakabayashi¹、Satoru Watanabe¹、Hiroshi Mori¹、Yuji Kunita¹、Takeshi Matsumura¹、Daiki Kayano²、Seigo Kinuya²、Koushiro Ohtsubo³ (1.Department of Nuclear Medicine, Kanazawa University Hospital, Ishikawa, Japan、2.Department of Nuclear Medicine, Kanazawa University Graduate School of Medical Sciences, Ishikawa, Japan、3.Depertment of Medical Oncology, Kanazawa University Hospital, Ishikawa, Japan)

[1-MO8-6]External dose rate change and treatment response in [¹⁷⁷Lu] DOTATATE therapy

Naoto Wakabayashi^1,2、Shiro Watanabe^1,2,3、Satoshi Takeuchi^4,5、Shintaro Takeuchi^5,6、Kenji Hirata^1,2,3,5、Rina Kimura^2,7、Junki Takenaka^2,8、Hiroto Koga^1,2、Kohsuke Kudo^2,3,7 (1.Department of Nuclear Medicine, Hokkaido University Hospital, Hokkaido, Japan、2.Department of Diagnostic Imaging, Graduate School of Medicine, Hokkaido University, Hokkaido, Japan、3.Global Center for Biomedical Science and Engineering, Faculty of Medicine, Hokkaido University, Hokkaido, Japan、4.Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido, Japan、5.Neuroendocrine Tumor Center, Hokkaido University Hospital, Hokkaido, Japan、6.Department of Gastroenterological Surgery II, Faculty of Medicine, Hokkaido University, Hokkaido University, Hokkaido, Japan、7.Department of Diagnostic and Interventional Radiology, Sapporo, Japan、8.Univ Cli Wurzburg)

Back to Category List